Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Thumbnail

Ultra-processed foods linked to 32 adverse health outcomes, including CVD-related death and diabetes

Data from nearly 9.9 million participants were included in the team’s final analysis. The group emphasized the important role governments can play in trying to reverse the world's reliance on these products. 

Thumbnail

Family man from Netherlands named world’s longest-surviving heart transplant recipient

The 57-year-old father of two is still in good health decades after receiving a new heart. 

Thumbnail

‘Just like smoking tobacco’: Cannabis use increases stroke risk by 42%, heart attack risk by 25%

“It can be a challenging discussion to have with patients because there is evidence that cannabis has some therapeutic properties," one researcher said. "However, as suggested by this study, cannabis use also has significant cardiovascular risks.”  

Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for its Agent Drug-Coated Balloon (DCB) for the treatment of coronary in-stent restenosis (ISR) in patients with coronary artery disease.

FDA approves Boston Scientific’s new drug-coated balloon for coronary in-stent restenosis

Interventional cardiologists have been anticipating this news for quite some time. The device, the first of its kind, provides an alternative treatment option to repeat PCI or cardiac surgery for patients with coronary ISR.

Nauman Mushtaq, MD, Northwestern Medicine, explains the value of CT coronary calcium scoring for patients and for the cardiology business model.

The many benefits of using low-cost CT coronary calcium scoring to screen patients

CT calcium scoring provides valuable evaluations of intermediate-risk patients in addition to making good business sense for hospitals. Nauman Mushtaq, MD, an interventional cardiologist with Northwestern, shared his own experience with this technology. 

Gen 2 Aria CV Pulmonary Hypertension System implanted in patient for first time.

World’s first patient treated with new implantable device for pulmonary hypertension

The procedure, performed on Feb. 14, was part of an early feasibility trial developed with help from the FDA.

healthcare business deal

Cardiologists partner with imaging AI specialists to improve care for high-risk heart patients

The new collaboration is designed to ensure patients who may face an increased risk of heart disease receive the follow-up care they need.

Biosense Webster gained CE mark approval for its Varipulse pulsed field ablation (PFA) system in Europe

Biosense Webster gains CE mark approval for new PFA system

The news represents yet another big regulatory approval for PFA technology in 2024. Could FDA approval be next for Biosense Webster?

Displaying 937 - 944 of 11116

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.